SGMO SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001172661-26-003615
SGMO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G for Sangamo Therapeutics, indicating a change in passive ownership position.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Sangamo Therapeutics, indicating a change in passive ownership position. The filing text does not disclose specific ownership percentages or share counts.
Key details
✦ Ask GOAX AI about this filing — what it means for SGMO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SGMO?
Click hereFrequently asked questions
What did SGMO file with the SEC on Aug 14, 2026?
SGMO filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Sangamo Therapeutics, indicating a change in passive ownership position. The filing text does not disclose specific ownership percentages or share counts.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other SGMO SEC filings
Get alerts when SGMO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days